Deconstructing Antiobesity Compound Action: Requirement of Serotonin 5-HT(2B) Receptors for Dexfenfluramine Anorectic Effects

The now-banned anorectic molecule, dexfenfluramine, promotes serotonin release through a serotonin transporter-dependent mechanism, and it has been widely prescribed for the treatment of obesity. Previous studies have identified that 5-HT(2B) receptors have important roles in dexfenfluramine side ef...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Banas, Sophie M, Doly, Stéphane, Boutourlinsky, Katia, Diaz, Silvina L, Belmer, Arnauld, Callebert, Jacques, Collet, Corinne, Launay, Jean-Marie, Maroteaux, Luc
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Nature Publishing Group 2011
Gaiak:
Original Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3055663/
https://ncbi.nlm.nih.gov/pubmed/20927048
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/npp.2010.173
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak